As a long-acting nonsteroidal anti-inflammatory API, Piroxicam CAS 36322-90-4 fully complies with USP43 pharmacopoeia standards and is widely used to manufacture oral and topical anti-inflammatory finished drugs. We are a professional Piroxicam CAS 36322-90-4 API Manufacturer with standardized GMP production workshops, supplying high-purity raw materials to global pharmaceutical formulation factories and generic drug enterprises.
Piroxicam CAS 36322-90-4 is a classic benzothiazine NSAID raw material strictly tested per USP43 requirements. It inhibits cyclooxygenase to block prostaglandin synthesis, delivering lasting analgesic, anti-inflammatory and antipyretic effects with an ultra-long half-life that supports once-daily administration. We provide Bulk API Order service and maintain Piroxicam CAS 36322-90-4 In Stock year-round, meeting mass continuous production demands and small trial batches for new formulation development. Our product adopts precise micronization & multi-stage recrystallization, with all known process impurities far below USP43 limits, lowering impurity research workload for overseas drug registration.
Product Parameters (Specification)
Parameter Item
Details
Parameter Item
Details
CAS No.
36322-90-4
Molecular Formula
C₁₅H₁₃N₃O₄S
Appearance
Off-white to light yellow crystalline powder
Purity
99.0%~101.0%
Execution Standard
BP/EP/USP
Packaging Specification
25kg/drum
Storage Conditions
Sealed, cool dry place, protected from light
Shelf Life
24 months
Product Features and Applications
Product Features
Long-lasting therapeutic effect: Extremely long plasma half-life enables single daily dosage, improving patient medication adherence and stabilizing clinical pain control;
Optimized micronized particle size: Uniform fine powder below 20μm, greatly boosting dissolution rate and bioavailability for oral tablets, capsules and topical gels;
Strict impurity control: Three key single impurities and total impurities all stay well under USP43 thresholds, simplifying impurity safety evaluation for finished drug registration;
Multi-formulation compatibility: Matches common excipients for oral solid preparations, external ointments and compound anti-inflammatory formulations without incompatibility risk.
Application Scenarios
Chronic arthritis oral drugs: Core raw material for rheumatoid arthritis, osteoarthritis and ankylosing spondylitis capsules/tablets to relieve joint swelling, stiffness and persistent pain;
Acute pain treatment preparations: Used for finished medicines targeting acute gout attacks, post-traumatic soft tissue contusion and sports strain pain;
Topical anti-inflammatory gel raw material: Applied to external formulations for local muscle soreness, joint inflammation and soft tissue inflammatory lesions;
Generic drug registration projects: Standard USP-grade API for overseas generic pharmaceutical factories developing low-cost long-acting NSAID finished products.
Procurement and Service Support
As your reliable Piroxicam CAS 36322-90-4 API Manufacturer, we deliver full-cycle professional procurement matching services:
Flexible tiered pricing for Bulk API Order: Long-term cooperative pharmaceutical manufacturers obtain volume discounts and priority production scheduling to shorten delivery cycles;
Stable Piroxicam CAS 36322-90-4 In Stock reserve: Multiple batches kept in constant inventory to support urgent shipment and prevent production line shutdown caused by raw material shortage;
Complete regulatory supporting documents: Supply full USP43-compliant COA, batch manufacturing records, MSDS and audit dossiers to satisfy FDA and overseas market registration & factory inspection requirements;
Customized technical support: Professional R&D team provides particle size adjustment guidance and formulation compatibility testing solutions for downstream customers.
Hot Tags: Piroxicam CAS 36322-90-4, China, Manufacturer, Supplier, Factory
If you have any enquiry about quotation or cooperation, please feel free to email or use the following inquiry form. Our sales representative will contact you within 24 hours.
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy